Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Enovix | ENVX | Dec 26, 2024 | 11.42 | +13.29 |
Enphase Energy | ENPH | Dec 26, 2024 | 73.01 | -0.37 |
Enpro | NPO | Dec 26, 2024 | 176.09 | +0.78 |
Enservco | ENSV | Dec 26, 2024 | 0.05 | -4.57 |
Enstar Group | ESGR | Dec 26, 2024 | 321.80 | -0.11 |
Enstar Group Depository E Pref | ESGRO | Dec 26, 2024 | 19.65 | -0.55 |
Enstar Pref | ESGRP | Dec 26, 2024 | 19.46 | -0.76 |
Ensysce Biosciences | ENSC | Dec 26, 2024 | 9.36 | -6.21 |
Entegris | ENTG | Dec 26, 2024 | 102.23 | -0.60 |
Entera Bio | ENTX | Dec 26, 2024 | 2.15 | -1.15 |
Entergy | ETR | Dec 26, 2024 | 75.94 | -0.38 |
Entergy Texas A Pref | ETI- | Dec 26, 2024 | 23.44 | +1.03 |
Entergy Utility Enterprises | EMP | Dec 26, 2024 | 21.55 | +0.28 |
Entero Therapeutics | ENTO | Dec 26, 2024 | 0.63 | -0.43 |
Enterprise Bancorp | EBTC | Dec 26, 2024 | 40.25 | 0.00 |
Enterprise Financial Services | EFSC | Dec 26, 2024 | 57.20 | +0.70 |
Enterprise Financial Services A Pref | EFSCP | Dec 26, 2024 | 19.68 | -1.50 |
Enterprise Products Partners LP Unit | EPD | Dec 26, 2024 | 31.14 | -1.11 |
Entrada Therapeutics | TRDA | Dec 26, 2024 | 17.74 | +1.03 |
Entravision Communications | EVC | Dec 26, 2024 | 2.40 | +0.84 |
Envela | ELA | Dec 26, 2024 | 7.25 | -0.89 |
Enveric Biosciences | ENVB | Dec 26, 2024 | 0.31 | 0.00 |
Envestnet | ENV | Dec 26, 2024 | 63.14 | 0.00 |
Enviri | NVRI | Dec 26, 2024 | 7.70 | +0.92 |
Environmental Svcs ETF Market Vectors | EVX | Dec 26, 2024 | 173.89 | +0.52 |
Envirotech Vehicles | EVTV | Dec 26, 2024 | 1.26 | +2.44 |
Envista | NVST | Dec 26, 2024 | 19.34 | +2.06 |
Envoy Medical A | COCH | Dec 26, 2024 | 1.72 | +9.55 |
enVVeno Medical | NVNO | Dec 26, 2024 | 3.06 | +8.51 |
Enzo Biochem | ENZ | Dec 26, 2024 | 0.71 | -2.56 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.